BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38189777)

  • 1. A PAX5 P80R pediatric B acute lymphoblastic leukemia with monocytic lineage switch at diagnosis: Deciphering classification ambiguity.
    Strullu M; Caye-Eude A; Fenneteau O; Arfeuille C; Cuccuini W; Cavé H; Baruchel A; Lainey E
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30842. PubMed ID: 38189777
    [No Abstract]   [Full Text] [Related]  

  • 2. DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch.
    Novakova M; Zaliova M; Fiser K; Vakrmanova B; Slamova L; Musilova A; Brüggemann M; Ritgen M; Fronkova E; Kalina T; Stary J; Winkowska L; Svec P; Kolenova A; Stuchly J; Zuna J; Trka J; Hrusak O; Mejstrikova E
    Haematologica; 2021 Aug; 106(8):2066-2075. PubMed ID: 32646889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol.
    Jung M; Schieck M; Hofmann W; Tauscher M; Lentes J; Bergmann A; Stelter M; Möricke A; Alten J; Schlegelberger B; Schrappe M; Zimmermann M; Stanulla M; Cario G; Steinemann D
    Genes Chromosomes Cancer; 2020 Nov; 59(11):667-671. PubMed ID: 32592278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of PAX5 intragenic tandem multiplication in pediatric B-lymphoblastic leukemia by optical genome mapping.
    Jean J; Kovach AE; Doan A; Oberley M; Ji J; Schmidt RJ; Biegel JA; Bhojwani D; Raca G
    Blood Adv; 2022 Jun; 6(11):3343-3346. PubMed ID: 35245931
    [No Abstract]   [Full Text] [Related]  

  • 5. Monocytoid switch in an adult with B-cell precursor acute lymphoblastic leukaemia characterised by the PAX5 P80R mutation.
    Mallik S; Yeung D; Rehn J; Nguyen T; Dunlop L; Kwan J; White D
    Pathology; 2022 Aug; 54(5):631-634. PubMed ID: 34924212
    [No Abstract]   [Full Text] [Related]  

  • 6. PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia.
    Li Y; Moriyama T; Yoshimura S; Zhao X; Li Z; Yang X; Paietta E; Litzow MR; Konopleva M; Yu J; Inaba H; Ribeiro RC; Pui CH; Yang JJ
    Sci Adv; 2022 Dec; 8(50):eadd6403. PubMed ID: 36516256
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Passet M; Boissel N; Sigaux F; Saillard C; Bargetzi M; Ba I; Thomas X; Graux C; Chalandon Y; Leguay T; Lengliné E; Konopacki J; Quentin S; Delabesse E; Lafage-Pochitaloff M; Pastoret C; Grardel N; Asnafi V; Lhéritier V; Soulier J; Dombret H; Clappier E;
    Blood; 2019 Jan; 133(3):280-284. PubMed ID: 30510083
    [No Abstract]   [Full Text] [Related]  

  • 8. PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia.
    Marincevic-Zuniga Y; Zachariadis V; Cavelier L; Castor A; Barbany G; Forestier E; Fogelstrand L; Heyman M; Abrahamsson J; Lönnerholm G; Nordgren A; Syvänen AC; Nordlund J
    Haematologica; 2016 Jan; 101(1):e20-3. PubMed ID: 26494837
    [No Abstract]   [Full Text] [Related]  

  • 9. PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia.
    Bastian L; Schroeder MP; Eckert C; Schlee C; Tanchez JO; Kämpf S; Wagner DL; Schulze V; Isaakidis K; Lázaro-Navarro J; Hänzelmann S; James AR; Ekici A; Burmeister T; Schwartz S; Schrappe M; Horstmann M; Vosberg S; Krebs S; Blum H; Hecht J; Greif PA; Rieger MA; Brüggemann M; Gökbuget N; Neumann M; Baldus CD
    Leukemia; 2019 Aug; 33(8):1895-1909. PubMed ID: 30842609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
    Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX5 fusion genes in acute lymphoblastic leukemia: A literature review.
    Fouad FM; Eid JI
    Medicine (Baltimore); 2023 May; 102(20):e33836. PubMed ID: 37335685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
    Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
    Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline PAX5 mutations and B cell leukemia.
    Hyde RK; Liu PP
    Nat Genet; 2013 Oct; 45(10):1104-5. PubMed ID: 24071841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
    Nasr MR; Rosenthal N; Syrbu S
    Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch.
    Nakajima K; Kubota H; Kato I; Isobe K; Ueno H; Kozuki K; Tanaka K; Kawabata N; Mikami T; Tamefusa K; Nishiuchi R; Saida S; Umeda K; Hiramatsu H; Adachi S; Takita J
    Cancer Sci; 2022 Jul; 113(7):2472-2476. PubMed ID: 35467057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia.
    Duployez N; Jamrog LA; Fregona V; Hamelle C; Fenwarth L; Lejeune S; Helevaut N; Geffroy S; Caillault A; Marceau-Renaut A; Poulain S; Roche-Lestienne C; Largeaud L; Prade N; Dufrechou S; Hébrard S; Berthon C; Nelken B; Fernandes J; Villenet C; Figeac M; Gerby B; Delabesse E; Preudhomme C; Broccardo C
    Blood; 2021 Mar; 137(10):1424-1428. PubMed ID: 33036026
    [No Abstract]   [Full Text] [Related]  

  • 17. PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia.
    Kim M; Choi JE; She CJ; Hwang SM; Shin HY; Ahn HS; Yoon SS; Kim BK; Park MH; Lee DS
    Blood Cells Mol Dis; 2011 Jun; 47(1):62-6. PubMed ID: 21549623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of PAX5 deletion in childhood B-lineage acute lymphoblastic leukemia without reproducible chromosomal abnormalities].
    Liu XM; Zhang L; Ruan M; Liu TF; Zhang JY; Liu F; Qi BQ; Chen XJ; Wang SC; Yang WY; Guo Y; Zou Y; Chen YM; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Apr; 18(4):287-91. PubMed ID: 27097569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.
    Nebral K; Denk D; Attarbaschi A; König M; Mann G; Haas OA; Strehl S
    Leukemia; 2009 Jan; 23(1):134-43. PubMed ID: 19020546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient with B-cell acute lymphoblastic leukemia with PAX5-ETV6 rearrangement with dic(9;12)(p13;p13) identified by chromosomal microarray.
    Ha J; Kim B; Hahn S; Lee ST; Lyu CJ; Choi JR
    Ann Hematol; 2018 Aug; 97(8):1505-1507. PubMed ID: 29520434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.